This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Aceragen Management
Management criteria checks 3/4
Aceragen's CEO is John Taylor, appointed in Sep 2022, he has a tenure of less than a year. His total yearly compensation is $444.06K , comprised of 17.5% salary and 82.5% bonuses, including company stock and options. He directly owns 17.45% of the company’s shares, worth $558.40K. The average tenure of the management team and the board of directors is 4.1 years and 4.3 years respectively.
How has John Taylor's remuneration changed compared to Aceragen's earnings?
Date
Total Compensation
Salary
Company Earnings
Mar 31 2023
n/a
n/a
-US$41m
Dec 31 2022
US$444k
US$78k
-US$23m
Compensation vs Market: John's total compensation ($USD444.06K) is below average for companies of similar size in the US market ($USD760.57K).
Compensation vs Earnings: Insufficient data to compare John's compensation with company performance.
CEO
John Taylor (52 yo)
less than a year
Tenure
US$444,062
Compensation
Mr. John C. Taylor serves as President, Chief Executive Officer and Director since September 28, 2022 at Aceragen, Inc. He was Chief Executive Officer of Spyryx Biosciences, Inc since December 2013 and ser...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
John Taylor
President
less than a year
US$444.06k
17.45% $ 558.4k
Gwen Thomas
Associate Director of Human Resources
no data
no data
no data
Christina Amendola
Director of Human Resources
no data
no data
no data
Brian Jackey
Senior Vice President of Technical Operations
no data
no data
no data
Deepa Nagpal
Global Head of Quality
no data
no data
no data
Shah Rahimian
Medical Director & Global Clinical Lead for Oncology
no data
no data
no data
Joanna Horobin
Advisor
4.1yrs
US$993.93k
no data
Louis Arcudi
Adviser
no data
US$986.13k
no data
4.1yrs
Average Tenure
62yo
Average Age
Experienced Management: ACGN's management team is considered experienced (4.1 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
John Taylor
President
less than a year
US$444.06k
17.45% $ 558.4k
Michael Dougherty
Independent Director
4.3yrs
US$89.43k
0.26% $ 8.4k
Vincent Milano
Chair of the Board of Directors
8.7yrs
US$1.43m
0.10% $ 3.2k
Ronald Wooten
Independent Director
less than a year
US$11.88k
no data
Maxine Gowen
Independent Director
7.6yrs
US$66.24k
0% $ 0
Cristina Csimma
Independent Director
4.3yrs
US$60.12k
0% $ 0
V. Sutton
Member of Scientific Advisory Board
no data
no data
no data
Edward Schuchman
Member of Scientific Advisory Board
no data
no data
no data
Atul Chopra
Member of Scientific Advisor Board
no data
no data
14.31% $ 458.0k
4.3yrs
Average Tenure
63.5yo
Average Age
Experienced Board: ACGN's board of directors are considered experienced (4.3 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2023/08/23 12:47
End of Day Share Price
2023/08/21 00:00
Earnings
2023/03/31
Annual Earnings
2022/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Aceragen, Inc. is covered by 8 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.